Montelukast Sodium Tablet, Film Coated
Product Images NDC 72789-306

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 72789-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789306 Label (72789306)

72789306 Label (72789306)
Montelukast Sodium USP 10 mg film-coated tablets packaging label by PD-Rx Pharmaceuticals, Inc. The label states 30 tablets per package with an expiration date of 08/2025 and lot number C23A58. The NDC number 72789-306-30 is visible along with dosage instructions and safety warnings.*
FDA Label Image

Figure1 (Montelukast Fig1)

Figure1 (Montelukast Fig1)
A line graph showing change in height (cm) over weeks on treatment for three groups: Montelukast 5 mg, Beclomethasone 336 mcg, and Placebo. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm. All groups demonstrate an increase in height over time with similar trends.*
FDA Label Image

Figure2 (Montelukast Fig2)

Figure2 (Montelukast Fig2)
A line graph depicting mean percent change from baseline in FEV1 over 15 weeks in a U.S. clinical trial comparing Montelukast Sodium and placebo. The x-axis shows weeks in treatment, and the y-axis shows mean percent change. Montelukast Sodium shows a higher increase over time compared to placebo, with a slight decline after week 12.*
FDA Label Image

Chemical Structure (Montelukast Str)

Chemical Structure (Montelukast Str)
Chemical structure diagram of montelukast sodium, showing its molecular arrangement including atoms such as chlorine, sulfur, and sodium, consistent with the active ingredient montelukast sodium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.